ID: ALA3350775

Max Phase: Preclinical

Molecular Formula: C27H29NNaO13P

Molecular Weight: 607.51

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@@H](N)[C@H](OP(=O)([O-])O)[C@H](C)O1.[Na+]

Standard InChI:  InChI=1S/C27H30NO13P.Na/c1-10-26(41-42(35,36)37)14(28)7-17(39-10)40-16-9-27(34,11(2)29)8-13-19(16)25(33)21-20(23(13)31)22(30)12-5-4-6-15(38-3)18(12)24(21)32;/h4-6,10,14,16-17,26,31,33-34H,7-9,28H2,1-3H3,(H2,35,36,37);/q;+1/p-1/t10-,14+,16-,17-,26+,27-;/m0./s1

Standard InChI Key:  PDOSXWCYPZTROB-XDKGUSKUSA-M

Associated Targets(Human)

A204 242 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T-24 2342 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

WiDr 1835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

IGR-37 cell line 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 607.51Molecular Weight (Monoisotopic): 607.1455AlogP: 1.15#Rotatable Bonds: 6
Polar Surface Area: 232.37Molecular Species: ZWITTERIONHBA: 12HBD: 6
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.83CX Basic pKa: 10.07CX LogP: 1.18CX LogD: -0.18
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.17Np Likeness Score: 1.71

References

1. Leenders RG, Scheeren HW, Houba PH, Boven E, Haisma HJ.  (1995)  Synthesis and evaluation of novel daunomycin-phosphate-sulfate --glucuronide and --glucoside prodrugs for application in adept,  (24): [10.1016/0960-894X(95)00523-3]

Source